Machine Learning Techniques for Pharmaceutical Bioinformatics

This dissertation presents a novel drug classifier to automate the prediction of drug indication and drug interactions with other drugs. The study integrates knowledge visualization, analysis, as well as development of a predictive model based on the Drug-Drug Interactions (DDIs) as a complex networ...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: SULTAN, AHMED ATTA AHMED (author)
منشور في: 2018
الموضوعات:
الوصول للمادة أونلاين:https://bspace.buid.ac.ae/handle/1234/1324
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1862980614676807680
author SULTAN, AHMED ATTA AHMED
author_facet SULTAN, AHMED ATTA AHMED
author_role author
dc.creator.none.fl_str_mv SULTAN, AHMED ATTA AHMED
dc.date.none.fl_str_mv 2018-11
2019-02-12T06:55:13Z
2019-02-12T06:55:13Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv 2016128022
https://bspace.buid.ac.ae/handle/1234/1324
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv The British University in Dubai (BUiD)
dc.subject.none.fl_str_mv machine learning
pharmaceutical bioinformatics
drug indication
Drug-Drug Interactions (DDIs)
drug repositioning
dc.title.none.fl_str_mv Machine Learning Techniques for Pharmaceutical Bioinformatics
dc.type.none.fl_str_mv Dissertation
description This dissertation presents a novel drug classifier to automate the prediction of drug indication and drug interactions with other drugs. The study integrates knowledge visualization, analysis, as well as development of a predictive model based on the Drug-Drug Interactions (DDIs) as a complex network. DDIs network analysis reveals unique drug features and explains unknown drug behaviors. Each drug molecule has a unique chemical structure and a set of pharmacological features. This set of attributes imposes how each drug performs its action inside a human body. Drug molecule interacts with multiple components in the biological system, for example, enzymes, proteins, among other drugs. The complexity of the chemical and pharmacological features forces the interaction between drug molecule and all other entities in the biological system to follow specific rules. The full features for each drug are not fully explained by researchers due to the incomplete drug profile description. DDIs network has a significant role in drug repurposing; it uncovers the hidden properties of the drug behavior. Predicting drug properties is presented as a contribution effort to drug repositioning approach. To confirm the visual analysis, a binary matrix is drawn from each drug profile based on DDIs dataset. In this matrix, each drug is represented by a vector of attributes from all other drugs. A predictive model is developed to predict drug indication as well as to predict new DDIs using multiple machine learning algorithms. This dissertation presents a case study of predicted anti-cancer activity for 38 drugs. The proposed Artificial Intelligence approach for drug-related properties prediction demonstrates a high potential in complementing the current computational techniques. The predicted anti-cancer activity is computationally validated by a 10-fold cross validation evaluation technique and clinically supported by extensive literature review confirming the achieved results. In conclusion, the predicted drug features can provide new directions towards promising candidates for drug repositioning.
id budr_d5e6fbc50f8a98c467e63e3f2acdf1f6
identifier_str_mv 2016128022
language_invalid_str_mv en
network_acronym_str budr
network_name_str The British University in Dubai repository
oai_identifier_str oai:bspace.buid.ac.ae:1234/1324
publishDate 2018
publisher.none.fl_str_mv The British University in Dubai (BUiD)
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Machine Learning Techniques for Pharmaceutical BioinformaticsSULTAN, AHMED ATTA AHMEDmachine learningpharmaceutical bioinformaticsdrug indicationDrug-Drug Interactions (DDIs)drug repositioningThis dissertation presents a novel drug classifier to automate the prediction of drug indication and drug interactions with other drugs. The study integrates knowledge visualization, analysis, as well as development of a predictive model based on the Drug-Drug Interactions (DDIs) as a complex network. DDIs network analysis reveals unique drug features and explains unknown drug behaviors. Each drug molecule has a unique chemical structure and a set of pharmacological features. This set of attributes imposes how each drug performs its action inside a human body. Drug molecule interacts with multiple components in the biological system, for example, enzymes, proteins, among other drugs. The complexity of the chemical and pharmacological features forces the interaction between drug molecule and all other entities in the biological system to follow specific rules. The full features for each drug are not fully explained by researchers due to the incomplete drug profile description. DDIs network has a significant role in drug repurposing; it uncovers the hidden properties of the drug behavior. Predicting drug properties is presented as a contribution effort to drug repositioning approach. To confirm the visual analysis, a binary matrix is drawn from each drug profile based on DDIs dataset. In this matrix, each drug is represented by a vector of attributes from all other drugs. A predictive model is developed to predict drug indication as well as to predict new DDIs using multiple machine learning algorithms. This dissertation presents a case study of predicted anti-cancer activity for 38 drugs. The proposed Artificial Intelligence approach for drug-related properties prediction demonstrates a high potential in complementing the current computational techniques. The predicted anti-cancer activity is computationally validated by a 10-fold cross validation evaluation technique and clinically supported by extensive literature review confirming the achieved results. In conclusion, the predicted drug features can provide new directions towards promising candidates for drug repositioning.The British University in Dubai (BUiD)2019-02-12T06:55:13Z2019-02-12T06:55:13Z2018-11Dissertationapplication/pdf2016128022https://bspace.buid.ac.ae/handle/1234/1324enoai:bspace.buid.ac.ae:1234/13242021-09-22T12:43:40Z
spellingShingle Machine Learning Techniques for Pharmaceutical Bioinformatics
SULTAN, AHMED ATTA AHMED
machine learning
pharmaceutical bioinformatics
drug indication
Drug-Drug Interactions (DDIs)
drug repositioning
title Machine Learning Techniques for Pharmaceutical Bioinformatics
title_full Machine Learning Techniques for Pharmaceutical Bioinformatics
title_fullStr Machine Learning Techniques for Pharmaceutical Bioinformatics
title_full_unstemmed Machine Learning Techniques for Pharmaceutical Bioinformatics
title_short Machine Learning Techniques for Pharmaceutical Bioinformatics
title_sort Machine Learning Techniques for Pharmaceutical Bioinformatics
topic machine learning
pharmaceutical bioinformatics
drug indication
Drug-Drug Interactions (DDIs)
drug repositioning
url https://bspace.buid.ac.ae/handle/1234/1324